AJ Melet is the CEO of a startup biotechnology company Ronawk Inc. Ronawk Inc’s technology involves growing cells in a tissue mimetic substrate called bio blocks. The cells grow in 3D and form their own micro tissues, which can be used to manufacture new therapies. Roanoke's technology has potential applications in tissue engineering and scaling the production of biological factors. The biggest challenges Roanoke is currently facing are building a new lab and getting people to understand the new technology. AJ Melet is inspired by people who serve others, concerned about our ability to connect in a digital world, and excited by people tackling big challenges.
Subscribe to Life Science Success for cutting-edge insights, expert interviews, and a vibrant community. Your subscription fuels our mission and keeps you at the forefront of life sciences.
